212 related articles for article (PubMed ID: 23403306)
1. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
3. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
5. Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.
Kim KY; Yi BR; Lee HR; Kang NH; Jeung EB; Kim SU; Choi KC
Int J Oncol; 2012 Apr; 40(4):1097-104. PubMed ID: 22159640
[TBL] [Abstract][Full Text] [Related]
6. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferon-beta via apoptotic pathway in the metastatic mouse model of breast cancer.
Yi BR; Kim SU; Choi KC
Oncotarget; 2016 Feb; 7(5):5985-99. PubMed ID: 26716512
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects.
Yi BR; O SN; Kang NH; Hwang KA; Kim SU; Jeung EB; Kim YB; Heo GJ; Choi KC
Int J Oncol; 2011 Oct; 39(4):833-9. PubMed ID: 21769425
[TBL] [Abstract][Full Text] [Related]
9. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
[TBL] [Abstract][Full Text] [Related]
10. Additional effects of engineered stem cells expressing a therapeutic gene and interferon-β in a xenograft mouse model of endometrial cancer.
Yi BR; Kim SU; Choi KC
Int J Oncol; 2015 Jul; 47(1):171-8. PubMed ID: 25963746
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.
Shin HJ; Hwang KA; Go RE; Kim SU; Choi KC
J Cell Biochem; 2020 Feb; 121(2):1586-1598. PubMed ID: 31512776
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse model.
Choi Y; Lee HK; Ahn D; Nam MW; Go RE; Choi KC
Life Sci; 2023 Sep; 328():121866. PubMed ID: 37331506
[TBL] [Abstract][Full Text] [Related]
15. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
[TBL] [Abstract][Full Text] [Related]
16. A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.
Heo JR; Hwang KA; Kim SU; Choi KC
Cancer Res Treat; 2019 Apr; 51(2):797-811. PubMed ID: 30213181
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells.
Kim HS; Yi BR; Hwang KA; Kim SU; Choi KC
Mol Cells; 2013 Oct; 36(4):347-54. PubMed ID: 24008363
[TBL] [Abstract][Full Text] [Related]
18. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.
Park GT; Heo JR; Kim SU; Choi KC
Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Specific Inhibitory Effects of Genetically Engineered Stem Cells Expressing Cytosine Deaminase and Interferon-β Against Choriocarcinoma in Xenografted Metastatic Mouse Models.
Kim GS; Heo JR; Kim SU; Choi KC
Transl Oncol; 2018 Feb; 11(1):74-85. PubMed ID: 29202279
[TBL] [Abstract][Full Text] [Related]
20. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]